Trial Profile
A Pilot Study of Decitabine and Vorinostat With Chemotherapy for Relapsed ALL
Status:
Discontinued
Phase of Trial:
Phase I/II
Latest Information Update: 28 Oct 2020
Price :
$35
*
At a glance
- Drugs Decitabine (Primary) ; Vorinostat (Primary) ; Dexamethasone; Methotrexate; Mitoxantrone; Pegaspargase; Vincristine
- Indications Precursor cell lymphoblastic leukaemia-lymphoma
- Focus Adverse reactions
- 22 Jan 2020 Results published in the Clinical Cancer Research
- 06 Dec 2016 Results presented at the 58th Annual Meeting and Exposition of the American Society of Hematology
- 15 Sep 2015 Status changed from recruiting to discontinued, as reported by ClinicalTrials.gov.